Cloning and the Debate on Abortion
By Nigel Cameron and Lori Andrews,
Chicago Tribune
| 08. 08. 2001
Italian fertility specialist Severino Antinori has announced
that he will begin human cloning in early 2002. Two hundred
couples desperately seeking to create children will become human
guinea pigs in a massive experiment. The odds are not in their
favor. In animals, cloning currently only results in a successful
pregnancy 3 to 5 percent of the time. And, even in those rare
instances, many of the resulting offspring suffer. One-third
die shortly before or right after birth. Other cloned animals
seem perfectly healthy at first and then suffer heart and blood
vessel problems, underdeveloped lungs, diabetes, immune system
deficiencies and severe growth abnormalities.
If an infectious disease were killing one-third of human infants,
we would declare it a public health emergency. We certainly
wouldn’t set up a clinic to enable it to happen. Yet despite
these grave risks, only five states have laws banning human
cloning. There is no federal law on the subject yet. Despite
widespread public opposition to human cloning, various researchers
and biotech companies have so far prevented the passage of such
a law.
This summer, however...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...